Centro de Investigación Médica Aplicada-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

    Journal of Hematology and Oncology, Vol. 10, Núm. 1

2015

  1. Deregulation of DNA double-strand break repair in multiple myeloma: Implications for genome stability

    PLoS ONE, Vol. 10, Núm. 3